Clinical Trial Update: Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification [Phase 3]

View source ↗

Summary

Phase 3 trial update for PRO-145 ophthalmic emulsion evaluating inflammation and pain after cataract surgery completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• PRO-145

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Cataract | Phase 3 | Status: COMPLETED | Results posted: 2019-12-02